1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page is an informational hub; links to separate funding opportunities page for active FOAs.
Special Statutory Funding Program for Type 1 Diabetes Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH. This federal program supports research on the prevention and cure of type 1 diabetes and its complications. The NIDDK oversees this program in collaboration with multiple NIH Institutes and Centers and CDC.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Type 1 Diabetes Special Statutory Funding Program - NIDDK Type 1 Diabetes Special Statutory Funding Program Type 1 Diabetes Special Statutory Funding Program The Special Statutory Funding Program for Type 1 Diabetes Research, or Special Diabetes Program, is a special appropriation that supports research on the prevention and cure of type 1 diabetes and its complications.
Since 1998, the Special Diabetes Program has enabled the creation of unique, innovative, and collaborative research consortia and clinical trials networks . These have made significant research progress as noted in program reports and also generated numerous research resources for use by the broad scientific community.
The NIDDK administers the Special Diabetes Program on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, and with input from the Diabetes Mellitus Interagency Coordinating Committee . Learn more about the Program’s background .
The Special Diabetes Program supplements type 1 diabetes research supported by the NIDDK and NIH’s regular appropriation. Therefore, the links on this site do not represent the entirety of type 1 diabetes research supported by the NIDDK and the NIH, but rather focus only on research supported by the Special Diabetes Program. Learn more about NIDDK diabetes research .
Clinical Trials Recruiting Patients and Families Opportunities for participation in human research studies on type 1 diabetes View Clinical Trials Recruiting Patients & Families Announcements of solicitations to conduct type 1 diabetes research Programs for Small Businesses Materials and tools to enable type 1 diabetes research by the broad scientific community Ancillary Studies to major Ongoing Clinical Trials Consortia, Networks, and Centers Programs funded to create communities of researchers focused on answering complicated scientific questions together Basic and Pre-Clinical Research Consortia Clinical Research Consortia and Networks Standardization of Laboratory Measurements View Consortia, Networks and Centers Information on research activities and advances, goals, and coordination in type 1 diabetes research Federal Diabetes Research Coordination View Reports and Planning
According to the current listing, eligibility includes: Research institutions and organizations, administered by NIDDK in collaboration with multiple NIH Institutes and Centers and CDC. Confirm the full requirements in the official notice before applying.
The current listing shows $150 million annually (total program funding). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Special Statutory Funding Program for Type 1 Diabetes Research is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article